Abstract 3484: Analysis ofin situexpression of hormone receptors and proliferation marker at a single cell level in breast cancer tissues

Author(s):  
Takayuki Ueno ◽  
Hirotsugu Isaka ◽  
Hiroki Itoh ◽  
Kaisuke Miyamoto ◽  
Manami Kitamura ◽  
...  
2014 ◽  
Vol 9 (4) ◽  
pp. 749-757 ◽  
Author(s):  
Marta Pestrin ◽  
Francesca Salvianti ◽  
Francesca Galardi ◽  
Francesca De Luca ◽  
Natalie Turner ◽  
...  

2006 ◽  
Vol 56 (5) ◽  
pp. 1001-1010 ◽  
Author(s):  
Chris Heyn ◽  
John A. Ronald ◽  
Soha S. Ramadan ◽  
Jonatan A. Snir ◽  
Andrea M. Barry ◽  
...  

2019 ◽  
Vol 91 (5) ◽  
pp. 3667-3674 ◽  
Author(s):  
Ruihua Wang ◽  
Hansen Zhao ◽  
Xiaochao Zhang ◽  
Xu Zhao ◽  
Zhe Song ◽  
...  

2021 ◽  
Vol 14 (9) ◽  
pp. 918
Author(s):  
Yining Liu ◽  
Min Zhao

Many recent efforts have been put into the association between expression heterogeneity and different cell types and states using single-cell RNA transcriptome analysis. There is only limited understanding of gene dosage effects for the genetic heterogeneity at the single-cell level. By focusing on concordant copy number variation (CNV) and expression, we presented a computational framework to explore dosage effect for aggressive metastatic triple-negative breast cancer (TNBC) at the single-cell level. In practice, we collected CNV and single-cell expression data from the same patients with independent technologies. By focusing on 47,198 consistent copy number gains (CNG) and gene up-regulation from 1145 single cells, ribosome proteins with important roles in protein targeting were enriched. Independent validation in another metastatic TNBC dataset further prioritized signal recognition particle-dependent protein targeting as the top functional module. More interesting, the increased ribosome gene copies in TNBC may associate with their enhanced stemness and metastatic potential. Indeed, the prioritization of a well-upregulated functional module confirmed by high copy numbers at the single-cell level and contributing to patient survival may indicate the possibility of targeted therapy based on ribosome proteins for TNBC.


Sign in / Sign up

Export Citation Format

Share Document